Conflicting results from anti-TNF trials in sepsis patients suggest that timely administration of TNF inhibitor drugs is crucial.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
BMC Gastroenterology Open Access 28 May 2021
-
ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
Cell Death & Disease Open Access 01 February 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Heumann D. & Glauser M.P. Pathogenesis of sepsis. Sci. Am. Med. 1, 28–37 (1994).
Dellinger, R.P. et al. From the bench to the bedside: The future of sepsis research. Chest 111, 744–753 (1997).
Abraham E. et al. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. JAMA 277, 1531–1538 (1997).
Van Zee K.J. et al. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-lg fusion protein, Ro 45-2081. J. Immunol. 156, 2221–2230 (1996).
Cohen, J., Heumann D. & Glauser M.P. Do monoclonal antibodies and anticytokines still have a future in infectious diseases. Am. J. Med. 99, 45S–52S (1995).
Lesslauer, W. et al. Recombinant soluble TNF receptor proteins protect mice from LPS-induced lethality. Eur. J. Immunol. 21, 2883–2886 (1991).
Munoz, C. et al. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol. 21, 2177–2184 (1991).
Andrejko, K.M. & Deutschman, C.S. Acute-phase gene expression correlates with intrahepatic tumor necrosis factor alpha abundance but not with plasma tumor necrosis factor concentrations during sepsis/systemic inflammatory response syndrome in the rat. Crit. Care Med. 24, 1947–1952 (1996).
Pellegrini, J.D., Puyana, J.C., Lapchak, P.H., Kodys, K. & Millergraziano, C.L. A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality. Shock 6, 389–396 (1996).
Wallach, D. A decade of accumulated knowledge and emerging answers. The 6th International Congress on TNF, Rhodes, Greece. May 1996. Eur. Cytokine Netw. 7, 713–724 (1996).
Vandenabeele, P., Declercq, W., Beyaert, R. & Fiers, W. Two tumor necrosis factor receptors: Structure and function. Tr. Cell Biol. 5, 392–399 (1995).
Evans, T.J. et al. Protective effect of 55-but not 75kD soluble tumor necrosis factor receptor immunoglobulin G fusion proteins in an animal model of gram-negative sepsis. J. Exp. Med. 180, 2173–2179 (1994).
Kwiatkowski, D. et al. Response to monoclonal anti-TNF antibody in children with cerebral malaria. Q. J. Med. 86, 91–98 (1993)
Brouckaert, P. et al. Inhibition of and sensitization to the lethal effects of tumor necrosis factor. J. Inflamm. 47, 18–26 (1996).
Döcke, W.D. et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment. Nature Med. 3, 678–681 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grau, G., Maennel, D. TNF inhibition and sepsis — sounding a cautionary note. Nat Med 3, 1193–1195 (1997). https://doi.org/10.1038/nm1197-1193
Issue Date:
DOI: https://doi.org/10.1038/nm1197-1193
This article is cited by
-
Selective inhibition of soluble TNF using XPro1595 relieves pain and attenuates cerulein-induced pathology in mice
BMC Gastroenterology (2021)
-
ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer
Cell Death & Disease (2021)
-
Interleukin-6: designing specific therapeutics for a complex cytokine
Nature Reviews Drug Discovery (2018)
-
A Simple Mathematical Model of Cytokine Capture Using a Hemoadsorption Device
Annals of Biomedical Engineering (2009)
-
Experimental Validation of a Theoretical Model of Cytokine Capture Using a Hemoadsorption Device
Annals of Biomedical Engineering (2009)